Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INTEGRA LIFESCIENCES HOLDINGS CORPIART · Entity 2707 | Corp VP, Global Ops & Supp Chn | February 13, 2020 | February 18, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INTEGRA LIFESCIENCES HOLDINGS CORP
Report date February 13, 2020 · Filed February 18, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,542 |
Ending reported balance
After 2020-02-13 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2020-02-13 · Grant · Acquired 1,110 · Balance 16,520 F1: On February 13, 2020, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2019, at least 9% and up to a maximum of 33% cumulative increase in annual revenue over the 2016 fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 34% of the shares will vest on March 13, 2020 at 150% of target, the third anniversary of the grant date. Row 2 · 2020-02-13 · Grant · Acquired 503 · Balance 17,023 F2: On February 13, 2020, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2019 under the March 13, 2018 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2020 at 97% of target, the second anniversary of the grant date. Row 3 · 2020-02-13 · Grant · Acquired 519 · Balance 17,542 F3: On February 13, 2020, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2019 under the March 13, 2019 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2020 at 97% of target, the first anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: On February 13, 2020, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2019, at least 9% and up to a maximum of 33% cumulative increase in annual revenue over the 2016 fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 34% of the shares will vest on March 13, 2020 at 150% of target, the third anniversary of the grant date.
F2: On February 13, 2020, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2019 under the March 13, 2018 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2020 at 97% of target, the second anniversary of the grant date.
F3: On February 13, 2020, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2019 under the March 13, 2019 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2020 at 97% of target, the first anniversary of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 13, 2020 Filed Feb 18, 2020 22:01 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 519 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010245 · doc4.xml · nonDerivative · entry 3 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,542 F3 · shares: On February 13, 2020, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2019 under the March 13, 2019 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2020 at 97% of target, the first anniversary of the grant date. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:01 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 503 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010245 · doc4.xml · nonDerivative · entry 2 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,023 F2 · shares: On February 13, 2020, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2019 under the March 13, 2018 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2020 at 97% of target, the second anniversary of the grant date. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:01 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 1,110 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010245 · doc4.xml · nonDerivative · entry 1 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,520 F1 · shares: On February 13, 2020, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2019, at least 9% and up to a maximum of 33% cumulative increase in annual revenue over the 2016 fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 34% of the shares will vest on March 13, 2020 at 150% of target, the third anniversary of the grant date. Read SEC document |
| September 12, 2019 Filed Sep 13, 2019 20:13 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 609 | $0.00 Strike: $56.23 | $0.00 |
DisclosureSEC source: 0001209191-19-049474 · doc4.xml · derivative · entry 12 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,830 Underlying: Common Stock · 609 shares Expires 2026-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: 25% of the shares of stock options will vest each of the first, second, third and fourth anniversaries of the grant date of 3/13/2018. Read SEC document |
| September 12, 2019 Filed Sep 13, 2019 20:13 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,681 | $0.00 Strike: $43.68 | $0.00 |
DisclosureSEC source: 0001209191-19-049474 · doc4.xml · derivative · entry 11 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,682 Underlying: Common Stock · 1,681 shares Expires 2025-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: 25% of the shares of stock options will vest each of the first, second, third and fourth anniversaries of the grant date of 3/13/2017. Read SEC document |
| September 12, 2019 Filed Sep 13, 2019 20:13 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 3,663 | $0.00 Strike: $32.59 | $0.00 |
DisclosureSEC source: 0001209191-19-049474 · doc4.xml · derivative · entry 10 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,221 Underlying: Common Stock · 3,663 shares Expires 2024-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 25% of the shares of stock options will vest each of the first, second, third and fourth anniversaries of the grant date of 3/14/2016. F4 · balance_after: In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to eflect the two-for-one stock split that occurred on December 21, 2016. Read SEC document |
| September 12, 2019 Filed Sep 13, 2019 20:13 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 3,296 | $0.00 Strike: $26.87 | $0.00 |
DisclosureSEC source: 0001209191-19-049474 · doc4.xml · derivative · entry 9 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,296 shares Expires 2023-03-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the shares of stock options will vest each of the first, second, third and fourth anniversaries of the grant date of 3/23/2015. F2 · balance_after: 25% of the shares of stock options will vest each of the first, second, third and fourth anniversaries of the grant date of 3/23/2015. F3 · balance_after: This option was previously reported as covering 1,426 shares at an exercise price of $62.10 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015. F4 · balance_after: In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to eflect the two-for-one stock split that occurred on December 21, 2016. Read SEC document |
| September 12, 2019 Filed Sep 13, 2019 20:13 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 3,663 | $62.53 | $229,052.88 |
DisclosureSEC source: 0001209191-19-049474 · doc4.xml · nonDerivative · entry 8 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,410 F1 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $62.17 to $63. Read SEC document |
| September 12, 2019 Filed Sep 13, 2019 20:13 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionCommon Stock | 3,663 | $32.59 | $119,358.86 |
DisclosureSEC source: 0001209191-19-049474 · doc4.xml · nonDerivative · entry 7 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,073 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 12, 2019 Filed Sep 13, 2019 20:13 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 1,681 | $62.53 | $105,115.45 |
DisclosureSEC source: 0001209191-19-049474 · doc4.xml · nonDerivative · entry 6 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,410 F1 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $62.17 to $63. Read SEC document |
| September 12, 2019 Filed Sep 13, 2019 20:13 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionCommon Stock | 1,681 | $43.68 | $73,426.08 |
DisclosureSEC source: 0001209191-19-049474 · doc4.xml · nonDerivative · entry 5 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,091 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 12, 2019 Filed Sep 13, 2019 20:13 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 609 | $62.53 | $38,081.68 |
DisclosureSEC source: 0001209191-19-049474 · doc4.xml · nonDerivative · entry 4 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,410 F1 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $62.17 to $63. Read SEC document |
| September 12, 2019 Filed Sep 13, 2019 20:13 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionCommon Stock | 609 | $56.23 | $34,244.07 |
DisclosureSEC source: 0001209191-19-049474 · doc4.xml · nonDerivative · entry 3 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,019 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 12, 2019 Filed Sep 13, 2019 20:13 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 3,296 | $62.53 | $206,103.82 |
DisclosureSEC source: 0001209191-19-049474 · doc4.xml · nonDerivative · entry 2 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,410 F1 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $62.17 to $63. Read SEC document |
| September 12, 2019 Filed Sep 13, 2019 20:13 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionCommon Stock | 3,296 | $26.87 | $88,547.04 |
DisclosureSEC source: 0001209191-19-049474 · doc4.xml · nonDerivative · entry 1 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,706 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 22, 2019 Filed Aug 26, 2019 20:11 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 7,000 | $61.42 | $429,958.20 |
DisclosureSEC source: 0001209191-19-047400 · doc4.xml · nonDerivative · entry 1 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,410 Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 21:23 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 98 | $56.14 | $5,501.72 |
DisclosureSEC source: 0001209191-19-019771 · doc4.xml · nonDerivative · entry 8 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,410 Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 21:23 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 366 | $56.14 | $20,547.24 |
DisclosureSEC source: 0001209191-19-019771 · doc4.xml · nonDerivative · entry 7 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,508 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:23 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 2,913 | $0.00 Strike: $55.91 | $0.00 |
DisclosureSEC source: 0001209191-19-019771 · doc4.xml · derivative · entry 9 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,913 Underlying: Common Stock · 2,913 shares Expires 2027-03-13 F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/13/2019. Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:23 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 651 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-019771 · doc4.xml · nonDerivative · entry 6 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,874 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:23 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 242 | $55.91 | $13,530.22 |
DisclosureSEC source: 0001209191-19-019771 · doc4.xml · nonDerivative · entry 5 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,223 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:23 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 57 | $55.91 | $3,186.87 |
DisclosureSEC source: 0001209191-19-019771 · doc4.xml · nonDerivative · entry 4 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,465 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:23 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon stock | 79 | $55.91 | $4,416.89 |
DisclosureSEC source: 0001209191-19-019771 · doc4.xml · nonDerivative · entry 3 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,522 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:23 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 128 | $55.91 | $7,156.48 |
DisclosureSEC source: 0001209191-19-019771 · doc4.xml · nonDerivative · entry 2 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,601 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:23 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 296 | $55.91 | $16,549.36 |
DisclosureSEC source: 0001209191-19-019771 · doc4.xml · nonDerivative · entry 1 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,729 Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 21:54 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 464 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011130 · doc4.xml · nonDerivative · entry 3 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,025 F3 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018 under the March 13, 2018 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2019 at 89.5% of target, the first anniversary of the grant date. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 21:54 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 1,077 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011130 · doc4.xml · nonDerivative · entry 2 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,561 F2 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 33% of the shares will vest on March 13, 2019 at 150% of target, the second anniversary of the grant date. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 21:54 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 1,332 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011130 · doc4.xml · nonDerivative · entry 1 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,484 F1 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 34% of the shares will vest on March 14, 2019 at 150% of target, the third anniversary of the grant date. Read SEC document |
| March 23, 2018 Filed Mar 27, 2018 21:38 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 254 | $54.15 | $13,754.10 |
DisclosureSEC source: 0001209191-18-021801 · doc4.xml · nonDerivative · entry 2 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,152 Read SEC document |
| March 23, 2018 Filed Mar 27, 2018 21:38 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 255 | $54.15 | $13,808.25 |
DisclosureSEC source: 0001209191-18-021801 · doc4.xml · nonDerivative · entry 1 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,406 Read SEC document |
| March 14, 2018 Filed Mar 15, 2018 20:26 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 355 | $56.14 | $19,929.70 |
DisclosureSEC source: 0001209191-18-019844 · doc4.xml · nonDerivative · entry 5 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,031 Read SEC document |
| March 14, 2018 Filed Mar 15, 2018 20:26 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 95 | $56.14 | $5,333.30 |
DisclosureSEC source: 0001209191-18-019844 · doc4.xml · nonDerivative · entry 4 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,386 Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 20:26 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 2,439 | $0.00 Strike: $56.23 | $0.00 |
DisclosureSEC source: 0001209191-18-019844 · doc4.xml · derivative · entry 6 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,439 Underlying: Common Stock · 2,439 shares Expires 2026-03-13 F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/13/2018. Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 20:26 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 295 | $56.23 | $16,587.85 |
DisclosureSEC source: 0001209191-18-019844 · doc4.xml · nonDerivative · entry 3 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,481 Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 20:26 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 79 | $56.23 | $4,442.17 |
DisclosureSEC source: 0001209191-18-019844 · doc4.xml · nonDerivative · entry 2 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,776 Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 20:26 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 2,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-019844 · doc4.xml · nonDerivative · entry 1 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,855 Read SEC document |
| March 13, 2018 Filed Mar 21, 2018 20:10 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 630 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-021065 · doc4.xml · nonDerivative · entry 1 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,661 Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 21:30 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 1,075 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011355 · doc4.xml · nonDerivative · entry 3 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,187 F3 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 33% of the shares will vest on March 13, 2018 at 150% target, the first anniversary of the grant date. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 21:30 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 1,293 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011355 · doc4.xml · nonDerivative · entry 2 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,112 F2 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 33% of the shares will vest on March 14, 2018 at 150% target, the second anniversary of the grant date. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 21:30 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 928 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011355 · doc4.xml · nonDerivative · entry 1 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,819 F1 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least a 3% increase in annual revenue over the prior fiscal year, under the March 23, 2015 Performance Stock Award. Accordingly, 34% of the shares will vest on March 23, 2018, the third anniversary of the grant date. Read SEC document |
| March 24, 2017 Filed Mar 27, 2017 23:18 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 640 | $42.74 | $27,353.60 |
DisclosureSEC source: 0001209191-17-023011 · doc4.xml · nonDerivative · entry 4 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,891 Read SEC document |
| March 24, 2017 Filed Mar 27, 2017 23:18 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 641 | $42.74 | $27,396.34 |
DisclosureSEC source: 0001209191-17-023011 · doc4.xml · nonDerivative · entry 3 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,531 Read SEC document |
| March 23, 2017 Filed Mar 27, 2017 23:18 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 274 | $42.35 | $11,603.90 |
DisclosureSEC source: 0001209191-17-023011 · doc4.xml · nonDerivative · entry 2 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,172 Read SEC document |
| March 23, 2017 Filed Mar 27, 2017 23:18 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 274 | $42.35 | $11,603.90 |
DisclosureSEC source: 0001209191-17-023011 · doc4.xml · nonDerivative · entry 1 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,446 Read SEC document |
| March 14, 2017 Filed Mar 15, 2017 20:16 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 105 | $43.03 | $4,518.15 |
DisclosureSEC source: 0001209191-17-020789 · doc4.xml · nonDerivative · entry 3 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,720 Read SEC document |
| March 14, 2017 Filed Mar 15, 2017 20:16 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 393 | $43.03 | $16,910.79 |
DisclosureSEC source: 0001209191-17-020789 · doc4.xml · nonDerivative · entry 2 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,825 Read SEC document |
| March 13, 2017 Filed Mar 15, 2017 20:16 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 3,363 | $0.00 Strike: $43.68 | $0.00 |
DisclosureSEC source: 0001209191-17-020789 · doc4.xml · derivative · entry 4 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,363 Underlying: Common Stock · 3,363 shares Expires 2025-03-13 F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/13/2017. Read SEC document |
| March 13, 2017 Filed Mar 15, 2017 20:16 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 870 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-020789 · doc4.xml · nonDerivative · entry 1 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,218 Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 21:40 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 1,290 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-012173 · doc4.xml · nonDerivative · entry 3 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,348 F4 · shares: On February 15, 2017, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2016, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 33% of the shares will vest on March 14, 2017 at 150% target, the first anniversary of the grant date. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 21:40 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 898 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-012173 · doc4.xml · nonDerivative · entry 2 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,058 F3 · shares: On February 15, 2017, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2016, at least a 3% increase in annual revenue over the prior fiscal year, under the March 23, 2015 Performance Stock Award. Accordingly, 33% of the shares will vest on March 23, 2017, the second anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.